[Clinical experiences in the use of intravenously injectable tetanus-immune human gamma globulin TIG(i). II. Clinical and side effects (author's transl)]

[Article in Japanese]

Case Reports

[Article in Japanese]

I Ebisawa et al. Kansenshogaku Zasshi. 1981 Feb.

. 1981 Feb;55(2):101-8.

doi: 10.11150/kansenshogakuzasshi1970.55.101.

No abstract available

Similar articles

[Clinical experiences in the use of intravenously injectable tetanus-immune human gamma globulin TIG(i). I. Serum antitoxin levels following injection (author's transl)].
Ebisawa I, Matsuhashi C, Yamamoto A, Kurosu Y, Otsuka T. Ebisawa I, et al. Kansenshogaku Zasshi. 1981 Feb;55(2):92-100. doi: 10.11150/kansenshogakuzasshi1970.55.92. Kansenshogaku Zasshi. 1981. PMID: 6167649 Japanese. No abstract available.
[Adequate dosage of tetanus antitoxin and tetanus-immune human gamma globulin TIG in the treatment of tetanus].
Ebisawa I. Ebisawa I. Masui. 1974 May;23(5):381-7. Masui. 1974. PMID: 4137369 Review. Japanese. No abstract available.
Double-blind trial of equine antitoxin and human immune globulin in tetanus neonatorum.
McCracken GH Jr, Dowell DL, Marshall FN. McCracken GH Jr, et al. Lancet. 1971 Jun 5;1(7710):1146-9. doi: 10.1016/s0140-6736(71)91659-x. Lancet. 1971. PMID: 4102858 Clinical Trial. No abstract available.
Tetanus. Its prophylaxis and treatment.
Bernhardt LC, Hickey RC. Bernhardt LC, et al. Am J Surg. 1966 Jul;112(1):23-7. doi: 10.1016/s0002-9610(66)90534-4. Am J Surg. 1966. PMID: 4160796 No abstract available.
Current status of tetanus prophylaxis.
Furste W. Furste W. IMS Ind Med Surg. 1969 Aug;38(8):251-61. IMS Ind Med Surg. 1969. PMID: 4186247 Review. No abstract available.